相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7% Results From the CREDENCE Trial
Christopher P. Cannon et al.
CIRCULATION (2020)
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris Bikbov et al.
LANCET (2020)
Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials
Olivia R Ghosh-Swaby et al.
Lancet Diabetes & Endocrinology (2020)
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients
Peter Willeit et al.
CIRCULATION (2020)
Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes A Randomized Clinical Trial
Lori M. Laffel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Renal tubular markers as screening tools for severe vesicoureteral reflux
Victor Garcia-Nieto et al.
EUROPEAN JOURNAL OF PEDIATRICS (2019)
Elevated N-acetyl-β-D-glucosaminidase, a urinary tubular damage marker, is a significant predictor of carotid artery atherosclerosis in type 1 diabetes, independent of albuminuria: A cross-sectional study
Minyoung Lee et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2018)
Precision medicine in the management of type 2 diabetes
Anna L. Gloyn et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
Christoph Wanner et al.
CIRCULATION (2018)
N-Acetyl-β-D-Glucosaminidase Does Not Enhance Prediction of Cardiovascular or All-Cause Mortality by Albuminuria in a Low-Risk Population
Marit D. Solbu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Urinary N-acetyl-β-D-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes
So Ra Kim et al.
MEDICINE (2016)
Association Between Pulse Wave Velocity and a Marker of Renal Tubular Damage (N-Acetyl-β-D-Glucosaminidase) in Patients Without Diabetes
Motoshi Ouchi et al.
JOURNAL OF CLINICAL HYPERTENSION (2015)
Urinary n-acetyl-beta-d-glucosaminidase Excretion: an Indicator of Neuropathy in Type 2 Diabetes
S. Kopf et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2013)
Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes
Ferdau L. Nauta et al.
DIABETES CARE (2011)
Clinical outcome of renal tubular damage in chronic heart failure
Kevin Damman et al.
EUROPEAN HEART JOURNAL (2011)
Low-Grade Albuminuria Is Associated with Carotid Intima-Media Thickness in Chinese Type 2 Diabetic Patients
Yun Huang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
The Association of Microalbuminuria With Aortic Stiffness Is Independent of C-Reactive Protein in Essential Hypertension
Giuseppe Mule et al.
AMERICAN JOURNAL OF HYPERTENSION (2009)
Preventing cardiovascular disease and diabetes - A call to action from the American Diabetes Association and the American Heart Association
Robert H. Eckel et al.
CIRCULATION (2006)
Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients
G Mulè et al.
JOURNAL OF INTERNAL MEDICINE (2004)
分享论文
